FNDC5 and hepatocellular carcinoma: Zhang et al. revealed that serum irisin might be a novel biomarker in the diagnosis of hepatocellular carcinoma (HCC), and low preoperative serum irisin levels were significantly correlated with high comprehensive complication index scores after hepatectomy [38].